Stories | Patient Daily

Community

Marian Johns | Jan 25, 2018

National Toxicology Program has new associate director

+ Technology/Innovation

Marian Johns | Jan 24, 2018

NIH study indicates pauses in HIV treatment pose no major harm

Marian Johns | Jan 20, 2018

Study indicates iodine deficiency may effect chances of becoming pregnant

+ Technology/Innovation

Carol Ostrow | Jan 19, 2018

National Institutes of Health team traces developments in gene therapy treatments

+ Technology/Innovation

Carol Ostrow | Jan 19, 2018

Biotherapy firm cultivates potential cattle-based MERS treatment

Carol Ostrow | Jan 19, 2018

Wexler Medical Center named an accountable care organization to serve Medicare patients

Carol Ostrow | Jan 19, 2018

'Real science means something,' Napolitano says at start of medical school retreat

John Breslin | Jan 18, 2018

Early retirees, self-employed hit hardest by ACA premium increases

Trending

+ Pharmaceuticals

Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Pharmaceuticals

Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'